CD8A and neoplasm: Similarly, apigenin (25 mg/kg/day i.p. injected three times per week) reduced the number of g-MDSC and immunosuppressive TAM and increased mobilization of anti-tumor CD8+ cells in mice with orthotopic pancreatic cancer [195].